US 9868774
Anti-CD22 chimeric antigen receptors
granted A61KA61K38/00A61P
Quick answer
US patent 9868774 (Anti-CD22 chimeric antigen receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00, A61P35/02